srt2379
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 7, 2009 (NCT01018628)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Protein Sirt6INHIBITOR
SIRT6 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- srt2379
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01416376 | Phase 1 | Aug 30, 2011 | GlaxoSmithKline, Sirtris Pharmaceuticals |
| NCT01262911 | Phase 1 | Feb 1, 2011 | GlaxoSmithKline, Sirtris Pharmaceuticals |
| NCT01018628 | Phase 1 | Dec 7, 2009 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 3 | 1 | 1 | 2009 |
| Sirtris Pharmaceuticals | For profit | 2 | 2 | 1 | 2011 |
2 organizations
Page 1 / 1